Welcome to our dedicated page for Synchrony Financial SEC filings (Ticker: SYF), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Synchrony Financial filings document the regulatory record of a consumer finance company with common stock and preferred depositary shares listed on the New York Stock Exchange. Its Form 8-K reports include quarterly earnings releases, financial data supplements, presentations and monthly charge-off and delinquency statistics tied to the company’s credit portfolio.
The company’s proxy materials cover annual meeting matters, director elections, auditor ratification and advisory executive compensation votes. Other filings describe capital-structure activity, including public debt offerings under shelf registration statements, senior note indenture terms, preferred stock series and related exhibits.
Synchrony Financial (SYF) executive reports dividend-related equity awards. On 11/17/2025, an officer serving as EVP, CEO–Health & Wellness reported receiving 213 dividend equivalent units at a reference price of $70.47 per unit, tied to restricted stock units in Synchrony common stock. Following this, the officer beneficially owned 57,130 shares of common stock directly.
The filing also shows acquisition of 0.78 phantom stock units under the Synchrony Financial Deferred Compensation Plan, increasing total phantom stock units beneficially owned to 184.13. Both the dividend equivalent units and phantom stock units are described as economically equivalent to shares of Synchrony common stock, with the phantom units to be settled in cash six months after the officer’s separation from service, in line with plan terms.
Synchrony Financial director reports small increase in equity holdings. A company director of Synchrony Financial (SYF) filed a Form 4 detailing an automatic accrual of dividend equivalent units on November 17, 2025. The filing shows the acquisition of 15 dividend equivalent units at a reference price of $70.47 per unit, linked to previously granted restricted stock units. After this transaction, the reporting person beneficially owns 15,558 SYF shares or equivalents in direct ownership. These dividend equivalent units are economically equal to shares of common stock and will vest and settle on the same schedule and terms as the related restricted stock units.
Synchrony Financial director reported a routine equity-related transaction involving dividend equivalent units tied to restricted stock units. On November 17, 2025, the reporting person accrued 15 dividend equivalent units based on dividends paid on the common shares underlying existing restricted stock units at a referenced value of $70.47 per unit. Each unit is the economic equivalent of one share of Synchrony Financial common stock and will vest, settle, and expire on the same terms as the related restricted stock units.
Following this accrual, the reporting person beneficially owned 27,902 shares of Synchrony Financial common stock directly and 15,300 shares indirectly through family trusts. This reflects ongoing alignment of the director’s interests with shareholders through equity-based compensation rather than a discretionary open-market trade.
Synchrony Financial director Form 4 shows a small equity accrual. A company director reported acquiring 15 dividend equivalent units on 11/17/2025 at a price of $70.47 per unit. These units were credited as dividends on common shares underlying existing restricted stock units.
Following this transaction, the reporting person beneficially owns 29,869 Synchrony Financial common shares on a direct basis. Each dividend equivalent unit is the economic equivalent of one common share and will vest and settle on the same schedule and terms as the related restricted stock units.
Synchrony Financial (SYF) reported an insider equity accrual, as an executive officer acquired 213 dividend equivalent units on 11/17/2025 tied to existing restricted stock units. These units reflect dividends paid on the common shares underlying those awards and are economically equivalent to one share of Synchrony common stock each.
After this transaction, the reporting executive directly beneficially owned 108,484 common shares. The dividend equivalent units will vest and settle on the same schedule and terms as the related restricted stock units. The officer’s title is listed as EVP, CEO--Home & Auto.
Synchrony Financial (SYF) reported a routine insider update for one of its directors. On 11/17/2025, the director acquired 130 dividend equivalent units at $70.47 each. These units were accrued as dividends on the common shares underlying previously granted restricted stock units and deferred stock units under the company’s Long-Term Incentive Plans and Non-Employee Director Deferred Compensation Plan. After this transaction, the director beneficially owned 49,095 Synchrony Financial common shares in total.
Synchrony Financial (SYF) reported a small change in insider holdings for an executive. On November 17, 2025, an officer received 249 dividend equivalent units tied to previously granted restricted stock units. These units were valued at $70.47 each and are designed to mirror dividends paid on the underlying common shares.
After this transaction, the officer beneficially owns 58,530 Synchrony Financial common shares directly. The dividend equivalent units vest and settle on the same schedule and terms as the related restricted stock units and are economically equal to one share of common stock each. The reporting person serves as EVP, Chief Technology and Operating Officer of Synchrony Financial.
A director of Synchrony Financial (SYF) reported the automatic accrual of 15 dividend equivalent units on November 17, 2025. These units were credited as dividends paid on the common shares underlying the director’s restricted stock units. Each dividend equivalent unit is described as the economic equivalent of one share of Synchrony Financial common stock and will vest and settle on the same terms and schedule as the related restricted stock units.
Following this transaction, the director beneficially owns 3,312 Synchrony Financial common shares in direct form. The filing is a routine Form 4 disclosure of equity-based compensation rather than an open-market purchase or sale.
Synchrony Financial EVP reports multiple stock transactions. An executive officer of Synchrony Financial (SYF), serving as EVP, Chief Risk and Legal Officer, reported several transactions dated 11/17/2025. These included 238 dividend equivalent units acquired at $70.47, which mirror restricted stock units, and the sale of 20,000 shares of common stock at $72.80 under a Rule 10b5-1 trading plan adopted on July 28, 2025. The executive also exercised 12,000 employee stock options at $34.30 per share and sold 12,000 shares of common stock at $72.80 on the same date. Following these transactions, the executive directly beneficially owns 127,100 shares of Synchrony Financial common stock and 11,258 employee stock options.
Synchrony Financial director Form 4 filing reports that a board member received 148 dividend equivalent units of Synchrony Financial common stock on November 17, 2025. These units were accrued as dividends on common shares underlying previously granted restricted stock units and deferred stock units under the company’s Long-Term Incentive Plans and Non-Employee Director Deferred Compensation Plan.
Each dividend equivalent unit is the economic equivalent of one share of Synchrony Financial common stock. Following this transaction, the reporting person holds 38,074 shares of common stock directly and 34,106 shares indirectly through Guthrie 2012 Investments LP, for which he is investment manager and disclaims beneficial ownership except for his direct pecuniary interest.